Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Sell
32
PLSE Quote, Financials, Valuation and Earnings
Last price:
$14.07
Seasonality move
:
31.15%
Day range:
$14.28 - $14.80
52-week range:
$12.56 - $25.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11,044.59x
P/B ratio:
10.45x
Volume:
107.1K
Avg. volume:
196.9K
1-year change:
-23.12%
Market cap:
$968.7M
Revenue:
--
EPS (TTM):
-$1.14
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$500K | -- | -- | -- | $22.00 |
|
AORT
Artivion, Inc.
|
$110.6M | $0.15 | 19.64% | -75% | $51.71 |
|
EW
Edwards Lifesciences Corp.
|
$1.5B | $0.59 | 11.31% | -5.18% | $95.80 |
|
IVF
INVO Fertility, Inc.
|
$1.8M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.5M | -- | -54.48% | -57.14% | $2.23 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
$14.40 | $22.00 | $968.7M | -- | $0.00 | 0% | 11,044.59x |
|
AORT
Artivion, Inc.
|
$46.31 | $51.71 | $2.2B | -- | $0.00 | 0% | 4.88x |
|
EW
Edwards Lifesciences Corp.
|
$86.85 | $95.80 | $50.4B | 36.97x | $0.00 | 0% | 8.68x |
|
IVF
INVO Fertility, Inc.
|
$0.84 | -- | $12.7M | -- | $0.00 | 0% | 0.02x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.73 | $2.23 | $36.8M | -- | $0.00 | 0% | 2.42x |
|
NTRB
Nutriband, Inc.
|
$4.80 | $15.00 | $58.3M | -- | $0.00 | 0% | 23.95x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
7.84% | 1.721 | 0.66% | 9.82x |
|
AORT
Artivion, Inc.
|
37.39% | 2.234 | 13.06% | 1.88x |
|
EW
Edwards Lifesciences Corp.
|
6.42% | -0.140 | 1.55% | 2.86x |
|
IVF
INVO Fertility, Inc.
|
41.99% | -0.446 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 2.039 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 2.796 | 0.32% | 7.07x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PLSE
Pulse Biosciences, Inc.
|
-$449K | -$20.4M | -67.74% | -73.32% | -23682.56% | -$13.1M |
|
AORT
Artivion, Inc.
|
$70.9M | $11.6M | -1.36% | -2.63% | 10.26% | $15.9M |
|
EW
Edwards Lifesciences Corp.
|
$1.2B | $433.1M | 12.34% | 13.19% | 27.89% | $516.2M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
Pulse Biosciences, Inc. vs. Competitors
-
Which has Higher Returns PLSE or AORT?
Artivion, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of 5.73%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Artivion, Inc.'s return on equity of -2.63%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M AORTArtivion, Inc.62.55% $0.13 $700.7M -
What do Analysts Say About PLSE or AORT?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 52.78%. On the other hand Artivion, Inc. has an analysts' consensus of $51.71 which suggests that it could grow by 11.67%. Given that Pulse Biosciences, Inc. has higher upside potential than Artivion, Inc., analysts believe Pulse Biosciences, Inc. is more attractive than Artivion, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 AORTArtivion, Inc.4 1 0 -
Is PLSE or AORT More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison Artivion, Inc. has a beta of 1.601, suggesting its more volatile than the S&P 500 by 60.125%.
-
Which is a Better Dividend Stock PLSE or AORT?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Artivion, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Artivion, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or AORT?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Artivion, Inc. quarterly revenues of $113.4M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Artivion, Inc.'s net income of $6.5M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Artivion, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 11,044.59x versus 4.88x for Artivion, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M AORTArtivion, Inc.4.88x -- $113.4M $6.5M
-
Which has Higher Returns PLSE or EW?
Edwards Lifesciences Corp. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of 18.82%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Edwards Lifesciences Corp.'s return on equity of 13.19%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M EWEdwards Lifesciences Corp.78.29% $0.50 $10.9B -
What do Analysts Say About PLSE or EW?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 52.78%. On the other hand Edwards Lifesciences Corp. has an analysts' consensus of $95.80 which suggests that it could grow by 10.31%. Given that Pulse Biosciences, Inc. has higher upside potential than Edwards Lifesciences Corp., analysts believe Pulse Biosciences, Inc. is more attractive than Edwards Lifesciences Corp..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 EWEdwards Lifesciences Corp.15 13 0 -
Is PLSE or EW More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison Edwards Lifesciences Corp. has a beta of 0.968, suggesting its less volatile than the S&P 500 by 3.229%.
-
Which is a Better Dividend Stock PLSE or EW?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edwards Lifesciences Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Edwards Lifesciences Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or EW?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Edwards Lifesciences Corp. quarterly revenues of $1.6B. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Edwards Lifesciences Corp.'s net income of $292.3M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Edwards Lifesciences Corp.'s PE ratio is 36.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 11,044.59x versus 8.68x for Edwards Lifesciences Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M EWEdwards Lifesciences Corp.8.68x 36.97x $1.6B $292.3M
-
Which has Higher Returns PLSE or IVF?
INVO Fertility, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -150.51%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About PLSE or IVF?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 52.78%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 17091.98%. Given that INVO Fertility, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe INVO Fertility, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 IVFINVO Fertility, Inc.0 0 0 -
Is PLSE or IVF More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.540, suggesting its more volatile than the S&P 500 by 153.97%.
-
Which is a Better Dividend Stock PLSE or IVF?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or IVF?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than INVO Fertility, Inc. quarterly revenues of $1.8M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 11,044.59x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M IVFINVO Fertility, Inc.0.02x -- $1.8M -$2.6M
-
Which has Higher Returns PLSE or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -59.08%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About PLSE or NMTC?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 52.78%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.23 which suggests that it could grow by 204.92%. Given that NeuroOne Medical Technologies Corp. has higher upside potential than Pulse Biosciences, Inc., analysts believe NeuroOne Medical Technologies Corp. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is PLSE or NMTC More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.703, suggesting its less volatile than the S&P 500 by 29.673%.
-
Which is a Better Dividend Stock PLSE or NMTC?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NMTC?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 11,044.59x versus 2.42x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M NMTCNeuroOne Medical Technologies Corp.2.42x -- $2.7M -$1.6M
-
Which has Higher Returns PLSE or NTRB?
Nutriband, Inc. has a net margin of -22540.7% compared to Pulse Biosciences, Inc.'s net margin of -1118.87%. Pulse Biosciences, Inc.'s return on equity of -73.32% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital PLSEPulse Biosciences, Inc.-522.09% -$0.29 $100.6M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About PLSE or NTRB?
Pulse Biosciences, Inc. has a consensus price target of $22.00, signalling upside risk potential of 52.78%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 212.5%. Given that Nutriband, Inc. has higher upside potential than Pulse Biosciences, Inc., analysts believe Nutriband, Inc. is more attractive than Pulse Biosciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings PLSEPulse Biosciences, Inc.1 0 0 NTRBNutriband, Inc.1 0 0 -
Is PLSE or NTRB More Risky?
Pulse Biosciences, Inc. has a beta of 1.806, which suggesting that the stock is 80.579% more volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.907, suggesting its more volatile than the S&P 500 by 90.735%.
-
Which is a Better Dividend Stock PLSE or NTRB?
Pulse Biosciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pulse Biosciences, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PLSE or NTRB?
Pulse Biosciences, Inc. quarterly revenues are $86K, which are smaller than Nutriband, Inc. quarterly revenues of $346.1K. Pulse Biosciences, Inc.'s net income of -$19.4M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, Pulse Biosciences, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pulse Biosciences, Inc. is 11,044.59x versus 23.95x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PLSEPulse Biosciences, Inc.11,044.59x -- $86K -$19.4M NTRBNutriband, Inc.23.95x -- $346.1K -$3.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 29
Galecto, Inc. [GLTO] is down 12.13% over the past day.
Sell
20
SMX alert for Dec 29
SMX (Security Matters) Plc [SMX] is down 27.67% over the past day.
Sell
11
CDNAF alert for Dec 29
Canadian Tire Corp. Ltd. [CDNAF] is up 11.94% over the past day.
